Evidence map›Paper›PMID 35328381›Full record

ArticleInternational journal of molecular sciences2022

Inositol (1,4,5)-Trisphosphate Receptors in Invasive Breast Cancer: A New Prognostic Tool?

Arthur Foulon, Pierre Rybarczyk, Nicolas Jonckheere, Eva Brabencova, Henri Sevestre, Halima Ouadid-Ahidouch, Lise Rodat-Despoix

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. The IPBiochimica et biophysica acta. Molecular basis of disease · 2025
    Article
  3. S-acylation of CaChronic diseases and translational medicine · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Sodium regulates PLC and IPPhysiological reports · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Arthur FoulonCentre de Gynécologie-Obstétrique, Université Picardie Jules Verne, CHU Amiens Picardie, F-80089 Amiens, France.
Pierre RybarczykLaboratoire de Physiologie Cellulaire et Moléculaire, UR-UPJV-4667, Université Picardie Jules Verne, F-80090 Amiens, France.
Nicolas JonckheereUMR9020-U1277, CANTHER-Cancer Heterogeneity, Plasticity and Resistance to Therapies, CNRS, Inserm, CHU Lille, Univ. Lille, F-59000 Lille, France.ORCID 0000-0002-0496-0661
Eva BrabencovaJean-Godinot Institute Cancer Center, Centre de Lutte Contre le Cancer de Reims et Champagne Ardenne, Centre de Ressources Biologiques, F-51100 Reims, France.
Henri SevestreLaboratoire de Physiologie Cellulaire et Moléculaire, UR-UPJV-4667, Université Picardie Jules Verne, F-80090 Amiens, France.
Halima Ouadid-AhidouchLaboratoire de Physiologie Cellulaire et Moléculaire, UR-UPJV-4667, Université Picardie Jules Verne, F-80090 Amiens, France.
Lise Rodat-DespoixLaboratoire de Physiologie Cellulaire et Moléculaire, UR-UPJV-4667, Université Picardie Jules Verne, F-80090 Amiens, France.ORCID 0000-0002-2456-6039
Centre Hospitalier Universitaire Amiens-Picardie · FRLaboratoire de physiologie cellulaire et moléculaire · FRCentre National de la Recherche Scientifique · FRInstitut Jean Godinot · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is the leading cause of cancer death among women in worldwide and France. The disease prognosis and treatment differ from one breast cancer subtype to another, and the disease outcome depends on many prognostic factors. Deregulation of ion flux (especially Ca

Indexed as

Breast NeoplasmsCalciumEndoplasmic ReticulumFemaleHumansInositolInositol 1,4,5-Trisphosphate ReceptorsPrognosisCalciumInositolInositol 1,4,5-Trisphosphate Receptorsbreast cancerinositol 1,4,5 trisphosphateinvasive prognostic marker

Identifiers

PMID35328381
PMCPMC8955728
OpenAlexW4220903915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.